glp-1 shopping drug use cuts grocery spending by 6%, study finds Weight-loss drug users save more

Fragrances are a surprising category where sales are up as people take weight loss products

Benefits of Retatrutide From a scientific and clinical standpoint, Retatrutide offers several potential advantages: Triple hormonal action: Unlike single or dual receptor agonists, Retatrutide engages GLP-1, GIP, and glucagon pathways simultaneously, offering a broader metabolic effect

The product names may change, but the desire to find the perfect weight loss pill or supplement is timeless

A separate KFF analysis from March about Medicare Part D spending data from the Centers for Medicare & Medicaid Services found that gross Medicare spending on the three newest versions of GLP-1 diabetes medicines (Ozempic, Rybelsus and Mounjaro) that also have been approved for weight loss skyrocketed from $57 million in 2018 to $5.7 billion in 2022

Tirzepatide is presently being examined in a clinical trial (NCT04847557) for patients with moderate HF (NYHA class II-IV) with HFpEF [54]